These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 668190)

  • 41. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
    Land JM; Litwin J; Bigel P; Oberling F; Mayer S
    Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired lymphocyte function in untreated Hodgkin's disease.
    Levy R; Kaplan HS
    N Engl J Med; 1974 Jan; 290(4):181-6. PubMed ID: 4203007
    [No Abstract]   [Full Text] [Related]  

  • 45. Prostaglandin-producing suppressor cells in Hodgkin's disease.
    Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
    N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymphocyte function in patients with Hodgkin's disease.
    Rühl H; Vogt W; Rühl U
    G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunology and cellular biology of Hodgkin's disease.
    Slivnick DJ; Nawrocki JF; Fisher RI
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):205-20. PubMed ID: 2663823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mononuclear cells in sickle cell disease: subpopulations and in vitro response to mitogens.
    Hendriks J; De Ceulaer K; Williams E; Serjeant GR
    J Clin Lab Immunol; 1984 Mar; 13(3):129-32. PubMed ID: 6609238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
    Gupta S
    Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Monocyte cytotoxicity in Hodgkin's disease].
    Pehamberger H; Ludwig H; Pötzi P; Pietschmann H; Knapp W
    Acta Med Austriaca; 1979; 6(5):249-51. PubMed ID: 555222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Immunological aspects of Hodgkin's disease].
    Bianchini E
    Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins.
    Bockman RS
    J Clin Invest; 1980 Sep; 66(3):523-31. PubMed ID: 6967491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal lymphocyte responses in residents of a town with a cluster of Hodgkin's disease.
    Plouffe JF; Silva J; Schwartz RS; Callen JP; Kane P; Murphy LA; Goldstein IJ; Fekety R
    Clin Exp Immunol; 1979 Feb; 35(2):163-70. PubMed ID: 436334
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
    Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum zinc levels, lymphocyte counts and functions in pediatric Hodgkin's disease.
    Babacan E; Cavdar AO; Arcasoy A
    Boll Ist Sieroter Milan; 1977 Jul; 56(3):228-34. PubMed ID: 901636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Degrees of impairment of cell-mediated immune reactivity in Hodgkin's disease.
    Petrov M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):201-10. PubMed ID: 61913
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cellular immunity and clinico-histological stage in Hodgkin's disease].
    Fabris C; De Sanctis C; Ciriotti G; Ponzone A
    Minerva Pediatr; 1971 Feb; 23(5):190-3. PubMed ID: 5574421
    [No Abstract]   [Full Text] [Related]  

  • 60. [Antibody response in cultures of lymphocytes from patients with Hodgkin's lymphoma: role of monocytes].
    Villa ML; Colleoni M; Valenti F; Tondini C; Clerici E
    Boll Ist Sieroter Milan; 1987; 66(3):214-21. PubMed ID: 3325076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.